1-1 of 1
Hans Hagberg
Close
Sort by
Journal Articles

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)

Clinical Trials & Observations
Kristina Drott, Hans Hagberg, Karin Papworth, Thomas Relander, Mats Jerkeman
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1386–1392.
https://doi.org/10.1182/bloodadvances.2018019240
Published: 2018
Includes: Supplemental data